Please assess the completion status of the following clinical trial:

Trial Title: HEAL-HF: A Cardiac Resynchronization Therapy (CRT) Outcomes Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Ischemic cardiomyopathy~* Ejection Fraction (EF) \<= 35%~* QRS duration \>= 120 msec~* Standard heart failure (HF) oral medications for at least 1 month~* Evidence of mechanical dyssynchrony~* NYHA Class III or IV~Exclusion Criteria:~* Persistent or chronic atrial fibrillation (AF)~* Hemodynamically unstable or uncontrolled arrhythmias~* Unstable angina~* Aortic valve (AV) insufficiency or stenosis~* Mitral valve (MV) regurgitation \> 2+~* Active infection~* Contraindications for heparin~* Dependence on atrial pacing

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).